** Agency implements ICH Q1 and Q7 Guidelines ** ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6 ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6 ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6
** Agency implements ICH Q1 and Q7 Guidelines ** ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6 ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6 ** Customer Service Lines: For Enquiries call 0700-1-NAFDAC (0700-1-623322), For Complaints call 0800-1-NAFDAC (0800-1-6

Notes to Industry

The list below provides information gathered from press releases and other public notices of The Agency

Start DateEnd DateEventEvent TypeDirectorate
Unlocking the healthcare value chain: 2nd regional workshop on manufacturing Active Pharmaceutical Ingredients and excipients in NigeriaWorkshop
Regional Workshop on ICH Q1 - Stability Guideline (22nd - 24th July, 2024)Workshop
03/10/202306/10/2023Sustainable Healthcare Development: Workshop on Local Manufacturing of APIs and ExcipientsWorkshop
Stakeholders Meeting on Implementation of Pharmaceutical Traceability & Other Pertinent IssuesWorkshop
ICMRA Communication Campaign: World Antimicrobial Awareness Week 2022
World Antimicrobial Awareness Week
NAFDAC Celebrates International Anti-Corruption Day 2020
2020 Med Safety Week
3rd Annual African Medicines Quality Forum
Start DateEnd DateEventEvent TypeDirectorate
Title
17-May-21Recommendation For Emergency Use Authorization Of Janssen (Johnson & Johnson) Covid-19 Vaccine
20-Mar-21Covishield Vaccine Is Astrazeneca/Oxford University Vaccine
18-Feb-21NAFDAC Approves ASTRAZENECA/OXFORD COVID-19 (COVISHIELD) VACCINE
15-Jan-21Safety Of Covid Vaccines: What Nafdac Wants The Public To Know
Title
Title
11-Oct-23NAFDAC signs Memorandum of Understanding with the University of Medical Sciences…
11-Oct-23Official flag-off of NAFDAC Media Sensitisation Workshop on Dangers of Drug Hawking…
11-Oct-23NAFDAC Wants Personnel At Entry Points To Check Illicit Drug
26-May-23Dossier Submission Window Closes Soon
09-Feb-23Address of Director-General of NAFDAC, Prof. Moji Christianah Adeyeye Delivered at the Flag-off of North-West Zonal Media Sensitization Workshop on Dangers of Bleaching Creams on Thursday, 9TH February 2023 in Kano
25-Nov-22Public Announcement
25-Nov-22Notice To NAFDAC Clients On Implementation Of Tax Identification Number (TIN) Validation Issued By The Federal Inland Revenue Service On The NAFDAC Automated Products Administration And Monitoring System (NAPAMS) For Regulated Products Registration
28-May-21Fighting poor quality health products in times of Covid-19 and beyond: the need for a multi-stakeholder approach
07-Jun-20World Food Safety Day 2020 - Food Safety, Everyone's Business
02-May-20Disclaimer On The New Drug To Treatment Covid-19
23-Mar-20COVID-19: NAFDAC Issues Cautionary Regulatory Controls
03-Mar-20First Case Of Coronavirus Disease Confirmed In Nigeria
15-Feb-20Coronavirus (COVID-19) Outbreak
15-Feb-20Information On Vaccines, Drugs And Diagnostics For Coronavirus
04-Feb-20Public Announcement: Notification Of Newly Accredited Clean Report Of Inspection And Analysis (CRIA) Agents For China And India
01-Sep-19Public Announcement: NAFDAC eLicense Go-Live on National Single Window for Trade
16-Nov-18Notification: Digitization Of NAFDAC Registration Certificates And Notifications
20-Oct-18Chinese Drugs Containing Human Remains
28-Jun-18NAFDAC DG Identifies Causes Of Drug Abuse In Nigeria
17-Apr-18Stakeholder’s Workshop on NAFDAC Integration with Nigeria Trade Portal
09-Mar-18Consequences of Removing Drugs and Poisons from the Exclusive Legislative List
08-Mar-18NAFDAC Destroys N80 Million Counterfeit And Expired Regulated Products
08-Mar-18Drug Abuse: NAFDAC Impounds More Than Forty Containers Of Controlled Drugs
08-Mar-18Minister of Health Inaugurates NAFDAC Governing Council
26-Feb-18Yobe State Governor Donates Offices And Land To Nafdac
14-Feb-18Disclaimer on NAFDAC Recruitment!
01-Dec-17New NAFDAC DG Resumes Office, Talks Tough On Fight Against Counterfeit Products
20-Nov-17Chinese Authorities Recall Two Batches Of Canadian Baby Cereal
02-Sep-17Court Jails Graduate Five Years For Manufacturing Fake Drugs
02-Sep-17Restricting Use Of Codeine And Tramadol In Children, Recommending Against Use In Breastfeeding Women
13-Mar-14Basics of Biostatistics in Evidence-Driven Regulatory Decision Making
10-Dec-13US, EU And Others Congratulate Nigeria Over Orhii's Chairmanship Of World Anti-counterfeiting Mechanism
30-Nov-13NAFDAC DG Issues Disclaimer for FACEBOOK!
30-Nov-13Nigeria Appointed Chair of W.H.O. New Member State Mechanism
30-Nov-13NAFDAC/USP Collaborate on Road Map to Strengthen Medicine Quality
30-Nov-13NAFDAC and Kano State Government jointly destroys N600m fake drugs
30-Nov-13Nigerian texters to take on the drug counterfeiters
30-Nov-13NAFDAC introduces Small Business Support Desk
Title
26-Oct-24Transition from the STED Format to the IMDRF-ToC Template for Submission of Technical Documents to Support the Registration of Medical Devices
30-Apr-24Notice on New Window for Dossier Submissions
30-Apr-24Sources of API’s and Excipients
30-Apr-24Introduction of “Pre-Submission Meetings” for Submission of CTD Dossiers for Locally Manufactured Pharmaceutical Products.
24-Apr-24Directive Inclusion of Bioequivalent Data in Dossiers for Product Registration
27-Jun-23Notice To Clients On NAFDAC Guidelines For The Preparation Of Summary Of Product Characteristics (Smpc) For Drug Products In Nigeria (Human Drugs)
15-Nov-21NAFDAC Ceiling List
08-May-20Use of Online Platforms And Digital Tools
09-Apr-20Public Announcement: Instructions on CRIA during this lockdown #04201
20-Dec-19Post Marketing Surveillance On Food, Drug And Other Regulated Products #12191
20-Nov-19Full Implementation Of The Common Technical Document (CTD) Format #11191
16-Oct-19Active Pharmaceutical Ingredient(S) Import #10191
14-Aug-19Pre-Shipment Provisional Registration Of Imported Drugs And Other NAFDAC Regulated Products #07192
14-Jul-19Issuance Of E-Permit For Excipients #07191
01-May-19Commencement Of Five Plus Five Year Validity (Migration* To Local Production**) #03191R
17-Apr-19Five Plus Five-Year Validity (Migration* to Local Production**)
29-Mar-19Five-Year Exclusivity for Innovation # 03192
Title
Title
22-Jan-24Cold Chain Management
22-Jan-24Vaccine Types And Benefits: What You Need To Know
22-Jan-24What you Need to Know About Diphtheria Vaccines

More Actions